Abstract
"Compliance" is in the news these days. Its prominence in hypertension symposia now rivals that of the renin-angiotensin system; it has received independent billing in the Index Medicus, and of 15 drug advertisements in a recent issue of the Journal (November 10), 11 stress properties thought to enhance compliance and, thereby, efficacy.Yet is there any substance in all this hubub about compliance? The outbreak of publications since Blackwell's1 1973 review has spread in several directions, and three of them warrant discussion here.First of all, investigation has begun to show that more than intuition is needed to devise . . .

This publication has 3 references indexed in Scilit: